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Abstract
Background: The 14-3-3 proteins are structurally conserved throughout eukaryotes and participate in protein kinase
signaling. All 14-3-3 proteins are known to bind to evolutionally conserved phosphoserine-containing motifs (modes 1 and/
or 2) with high affinity. In Trypanosoma brucei, 14-3-3I and II play pivotal roles in motility, cytokinesis and the cell cycle.
However, none of the T. brucei 14-3-3 binding proteins have previously been documented.
Methodology/Principal Findings: Initially we showed that T. brucei 14-3-3 proteins exhibit far lower affinity to those
peptides containing RSxpSxP (mode 1) and RxY/FxpSxP (mode 2) (where x is any amino acid residue and pS is
phosphoserine) than human 14-3-3 proteins, demonstrating the atypical target recognition by T. brucei 14-3-3 proteins. We
found that the putative T. brucei protein phosphatase 2C (PP2c) binds to T. brucei 14-3-3 proteins utilizing its mode 3 motif
(–pS/pTx1-2-COOH, where x is not Pro). We constructed eight chimeric PP2c proteins replacing its authentic mode 3 motif
with potential mode 3 sequences found in Trypanosoma brucei genome database, and tested their binding. As a result, T.
brucei 14-3-3 proteins interacted with three out of eight chimeric proteins including two with high affinity. Importantly, T.
brucei 14-3-3 proteins co-immunoprecipitated with an uncharacterized full-length protein containing identified high-affinity
mode 3 motif, suggesting that both proteins form a complex in vivo. In addition, a synthetic peptide derived from this mode
3 motif binds to T. brucei 14-3-3 proteins with high affinity.
Conclusion/Significance: Because of the atypical target recognition of T. brucei 14-3-3 proteins, no 14-3-3-binding proteins
have been successfully identified in T. brucei until now whereas over 200 human 14-3-3-binding proteins have been
identified. This report describes the first discovery of the T. brucei 14-3-3-binding proteins and their binding motifs. The
high-affinity phosphopeptide will be a powerful tool to identify novel T. brucei 14-3-3-binding proteins.
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Introduction
Trypanosoma brucei is the causative agent of sleeping sickness in
man and nagana disease in cattle and one of the most divergent
eukaryotes from mammals. The disease is spread by the tsetse fly,
in which the procyclic forms (PCF) proliferate and differentiate
into bloodstream forms (BSF), the life stage that then proliferates
in the mammalian host. The disease is fatal if left untreated and no
effective drug is currently available for treatment of the late stage
of the disease (i.e., involvement of the central nervous system).
The 14-3-3 proteins are highly conserved dimeric acidic
proteins acting as phosphoserine/phosphothreonine-dependent
chaperones [1,2]. Homologues of 14-3-3 proteins have been
found in all eukaryotes [3,4]. Every organism expresses at least one
14-3-3 protein that binds to phosphopeptides containing consensus
motifs (mode 1 and/or mode 2) with high affinity (nanomolar
levels). The motifs include both RSxpSxP (mode 1) and RxY/
FxpSxP (mode 2) where pS is phosphoserine [5], and the recently
identified –pS/pTx1-2-COOH (mode 3) where x is not Pro [6].
Only limited number of proteins are known to have the mode 3
motif [7]. 14-3-3 proteins also have the ability to bind other than
the modes 1-3 motifs [8,9,10,11]. The latest bioinformatic and
experimental survey of 14-3-3-binding sites reveal that alternative
mode 1 Rxx(pS/pT)xP motifs dominate, although the last Pro
occurs less than half [12]. When 14-3-3 proteins bind to their
partners, the interacting partners may change their intracellular
localization, preference of interacting partners, or enzymatic
functions through conformational changes or masking of the
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the characterization of signal transduction pathways involving
kinase/phosphatase has progressed extensively through the
discovery of more than 200 14-3-3-interacting proteins, mainly
mediated by phosphorylated serine/threonine residue(s) of the
target proteins [13].
There is still a gap in our understanding of signal transduction
pathways in protozoan parasites including T. brucei. Although we
have previously reported that both T. brucei 14-3-3I and II proteins
play important roles in cell motility, cytokinesis and the cell cycle
[14], phosphoserine-dependent T. brucei 14-3-3-interacting pro-
teins have not been found until now in spite of extensive efforts.
Therefore, we examined the differences between human 14-3-3
isoforms and T. brucei 14-3-3 isoforms with respect to affinities to
various ligands. Here we provide several lines of evidence that the
14-3-3I, and especially the II, isoforms bind far less efficiently to
the conventional consensus motifs (modes 1 and 2). In addition,
heterodimerized 14-3-3I and II, the major existing forms in vivo
([14] and unpublished data), showed detectable affinities to the
chimeric proteins containing the mode 3 motif, leading us to
identify the T. brucei 14-3-3 binding proteins. The overall data
highlight the scarcity of 14-3-3 target proteins with high affinity in
the T. brucei cells and may indicate the divergent roles of T. brucei
14-3-3 proteins. The newly identified phosphopeptide that binds
to T. brucei 14-3-3 proteins may be utilized in isolating a novel class
of T. brucei 14-3-3 binding proteins, since over 200 human 14-3-3-
binding proteins can be purified from HeLa cell extracts by a
competitive elution from 14-3-3 affinity columns with alternative
mode 1 phosphopeptide or high-affinity peptide antagonist of 14-
3-3 proteins [13,15].
Results and Discussion
T. brucei 14-3-3 proteins only weakly bind with c-Raf and
conventional consensus phosphopeptides
Amino acid sequences of 14-3-3 proteins responsible for
monomer stabilization, dimer formation and serine/threonine-
phosphorylated motif binding are well conserved throughout the
eukaryotes [8,9,10,11]. The critical amino acid residues, with the
exception of those responsible for dimer formation [9,16,17] are
also conserved in T. brucei [14]. The high conservation of
sequences makes yeast 14-3-3 genes to be genetically exchangeable
with those of plants and mammals [18], and these 14-3-3 proteins
bind to human c-Raf 1 [18]. In addition, c-Raf 1 possesses at least
four 14-3-3 binding sites, namely Ser-259, Ser-621 and Ser-233, as
well as a site located in the Cys-rich domain between residues 136
and 187 [10]. Therefore, glutathione S-transferase (GST) pull-
down assay was carried out using HeLa cell lysates to examine
whether T. brucei 14-3-3I and/or II may also interact with human
c-Raf 1. The results showed that GST-14-3-3I bound weakly to c-
Raf 1 in comparison to human GST-14-3-3t and also that GST-
14-3-3II did not bind to c-Raf 1, suggesting that T. brucei 14-3-3I
and II do not have high affinities to human c-Raf 1 in spite of the
presence of the conserved putative structure of amphipathic
groove (Figure 1A and Figure S1). Thus, surface plasmon
resonance analysis utilizing BIAcore was performed to determine
the affinities to the conserved phosphopeptides. The mode 1
(RSxpSxP) and mode 2 (RxY/FxpSxP) phosphopeptide motifs are
present in many mammalian 14-3-3 binding proteins [5] and
mode 3 (–pS/pTx1-2-COOH) has been identified recently [6]. All
14-3-3 proteins so far identified have high affinity to these peptide
motifs [5,6,8,9,10,11]. However, the binding patterns of the
sensorgram shown in Figure 1B indicate that both maltose-binding
protein (MBP)-14-3-3I and GST-14-3-3I bind only weakly (slow
association and fast dissociation) to c-Raf-derived phosphopeptide
pSRaf259, a representative of mode 1 phosphopeptide, compared
with MBP/GST-14-3-3t, and MBP/GST-14-3-3II did not show
any interaction (Figure 1B, Mode 1, GST-14-3-3, MBP-14-3-3).
We also examined the interaction of mode 2 phosphopeptide
(biotin-MAGGGRLYHpSLP) with GST-14-3-3 proteins. The
patterns of the sensorgram indicated that GST-14-3-3t bound to
the mode 2 phosphopeptide but neither GST-14-3-3I nor GST–
14-3-3II showed any binding (Figure 1B, Mode 2). Comparison of
mode 1 and mode 2 sensorgram data showed a slightly higher
affinity of GST-14-3-3t with mode 1 than mode 2 peptide
(Figure 1B). We calculated the dissociation constant (Kd) of the
mode 1 phosphopeptide by using the BIAcore program (BIAeva-
luation 3.0). The estimated Kd of 14-3-3I was 4.8610
25 whereas
that of 14-3-3t was 2.2610
27. Interaction of 14-3-3II with the
mode 1 phosphopeptide was undetectable under these experi-
mental conditions. We also investigated the interactions of
endogenous 14-3-3I and II with the peptides pRaf259 and
pSRaf259, in which 259Ser are unphosphorylated and phosphor-
ylated, respectively. The peptide pull-down assay using T. brucei
PCF lysates showed that endogenous 14-3-3I and 14-3-3II did not
interact with either pRaf259 or pSRaf259 (Figure 1C). Longer
exposure revealed a weak interaction for 14-3-3II with both
pRaf259 and pSRaf259: the amount of captured 14-3-3II was not
different between phospho-(pSRaf259) and non-phospho-
(pRaf259) peptide-conjugated beads. No 14-3-3I was recovered
by the peptide-conjugated beads. These results indicate that T.
brucei 14-3-3 proteins possess far less affinity to the typical 14-3-3
binding motifs than 14-3-3 proteins from other species. Since all
the essential amino acid residues and sequences of a-helices
required for phosphopeptide binding in the putative amphipathic
groove are well conserved in T. brucei 14-3-3 (Figure S1), we
speculate a minor structural difference(s) or distinctive sequences
of N- and/or C- termini might influence the affinity to the
phosphopeptides.
The target proteins for T. brucei 14-3-3 interaction
Mammalian or yeast 14-3-3 proteins have been successfully
used as probes in far-Western blot (Far-WB) to identify direct
interactions with numerous target partners [13,15,19], although
the Far-WB assay has certain limitations related to the con-
formational state of the protein. Therefore, we used far-Western
blot (Far-WB) analysis to search for binding proteins of T. brucei
14-3-3. Lysates were prepared from HeLa and T. brucei PCF cells
treated with or without calyculin A (CalA), a serine/threonine
phosphatase inhibitor, to increase the number and amount of
phosphorylated proteins [13,20]. None of the proteins, except 14-
3-3 isoforms including putative dominant negative forms (I K77E
and II K56E) that correspond to human 14-3-3f K49E and 14-3-
3t K49E, respectively, interacted with T. brucei 14-3-3I and II as
shown the bands of approximately 28–30 kDa (Figure S1) [8]. The
14-3-3t proteins interacted with various proteins including
isoforms of human 14-3-3 proteins (Figure S2A). The number
and amounts of the 14-3-3t-interacting protein in both PCF and
HeLa cells increased upon CalA treatment (Figure S2A, GST-t),
as reported previously [13]. However, they were much less in PCF
cells than those in HeLa cells when human 14-3-3t protein was
used as a probe (Figure S2A, GST-t), suggesting that molecular
recognition of 14-3-3 proteins may co-evolve with their ligands. In
Arabidopsis, some isoforms of 14-3-3 increase the phosphoserine-
dependent target binding in the presence of divalent cations [21].
Therefore, we carried out Far-WB analysis in the presence of
1 mM CaCl2. However, no major difference in the interacting
protein was observed between CalA (2) and (+) in the presence or
Binding Motifs of T. brucei 14-3-3 Proteins
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brucei 14-3-3 to phosphopeptide-containing proteins is Ca
2+-
independent. The slight differences between Figure S2A (GST-
II) and Figure S2B (GST-II) are due to differences in the
concentration of the probes (1 mg/ml in Figure S2A, 2 mg/ml in
Figure S2B). The two minor bands (,66 and 70 KD) in the blots
incubated with GST alone were the non-specific bands from anti-
GST antibodies (Figure S2). Similar results were obtained when
digoxigenin-labeled non-fusion recombinant 14-3-3 proteins were
used as probes (data not shown), suggesting that the failure of
bindings of 14-3-3I and II is not due to the steric hindrance of
GST moiety. These results are consistent with the results of the
GST pull-down assay and the surface plasmon resonance analysis.
We have also used the heterodimerized form of GST-14-3-3II +I
(described in the next section) as a probe in Far-WB analysis and
obtained similar results (data not shown). Taken together, our
Figure 1. Interactions of T. brucei 14-3-3 proteins with c-Raf and the 14-3-3 binding phosphopeptide. (A) Interaction of GST-I, -II and t
with human c-Raf. HeLa cell lysates were subjected to GST pull-down assay using the indicated proteins bound to glutathione beads. Bound proteins
were separated with SDS-PAGE, transferred to a PVDF membrane and detected with a-human c-Raf-1 antibodies (WB). The membrane was stained
with coomassie brilliant blue (CBB) to visualize GST-14-3-3 proteins used in the assays. (B) Surface plasmon resonance measurements. Surface
plasmon resonance analysis of interaction of c-Raf-derived phosphopeptide pSRaf259 (biotin-MAGGGRQRSTpSTPN) (mode 1 peptide) to GST- and/or
MBP-14-3-3 fusion proteins. Surface plasmon resonance analysis of a mode 2 peptide (biotin-MAGGGRLYHpSLP) to GST-14-3-3 fusion proteins.
Sensorgram patterns are shown in each injected protein. (C) Peptide pull-down assay. T. brucei PCF cell lysates (5610
8 cells/pull-down) were
subjected to peptide pull-down assay followed by Western blotting (WB) with a-I or –II antibodies. WB of total cell lysates (1610
7 cells) using a-I and -
II detected bands of 28 kDa and 30 kDa, respectively.
doi:10.1371/journal.pone.0015566.g001
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not interact with the majority of human 14-3-3-binding proteins as
other 14-3-3 proteins from other eukaryotic organisms do.
Identification of T. brucei 14-3-3 binding protein with
high affinity
Since T. brucei 14-3-3 did not show high affinity to the mode 1 or
2 peptide, we searched the Trypanosoma brucei genome database
(GeneDB: http://www.genedb.org/genedb/tryp/index.jsp) for
the potential binding partners of T. brucei 14-3-3 proteins
containing a motif of –pS/pTx1-2-COOH (mode 3: where x is
not Pro). We first used Motif Search to extract the sequences
containing the mode 3 motif and then selected for the sequences
that could be phosphorylated by AGC kinase (PKA, PKG, PKC
or related kinases). We selected the putative AGC substrate
sequences, since AGC kinase are known to mediate diverse and
important cellular functions in mammalian cells. The selected
sequences were listed in Table 1.
We first examined whether a putative protein phosphatase 2c
(PP2c) in the list interacts with T. brucei 14-3-3 proteins, since the
phenotype of knockdown of 14-3-3I and/or II resembled that of
okadaic acid, a potent serine/threonine phosphatase inhibitor,
-treated T. brucei cells and PP2c has a putative mode 3 motif [22].
The N-terminally V5-tagged PP2c protein was expressed in
human HEK293T cells and purified by immunoprecipitation
using anti-V5 monoclonal antibody (Ab). Far-WB probing with
GST-14-3-3 proteins was used to detect the direct interaction. We
have recently identified the heterodimeric form as the major form
of T. brucei 14-3-3 proteins (unpublished data) and thus,
recombinant heterodimeric GST-II +I was used as a probe. The
results showed that V5-tagged PP2c (but not S744A mutant
protein which has Ala instead of Ser in the mode 3 motif), directly
bound to GST-14-3-3f with high affinity and to T. brucei GST-II
+I (heterodimerized recombinant proteins) with lower affinity
(Figure 2A upper panel). We further confirmed that the binding
was mediated by intact mode 3 motif (Figure 2B). Of note, PP2c
mutant without W at the C-terminal end (-W) showed much
higher affinity to dimeric T. brucei 14-3-3 proteins than wild type
PP2c (Figure 2B, lane 2).
We next examined whether T. brucei 14-3-3 proteins recognize
mode 1, 2 and 3 synthetic peptides spotted on a nitrocellulose filter.
Heterodimeric T. brucei 14-3-3 proteins failed to show the
interactions with these phosphopeptides (Table 1) including PP2c
and PP2c (-W), whereas human 14-3-3f showed strong interactions
(Figure 2C). The binding of T. brucei 14-3-3 proteins with PP2c
might require an additional sequence(s) to establish a stable
interaction. The other putative mode 3 synthetic phosphopeptides
derived from ACS (Table 1) would not interact either T. brucei 14-3-
3 or human 14-3-3f (Figure 2C). We next tested the association of
ectopically expressed V5-tagged PP2c with endogenous 14-3-3I and
II proteins in a Tet-inducible V5-tagged PP2c-expressing T. brucei
PCF clone. Immunoprecipitation with V5 monoclonal Ab followed
by Western blotting with a mixture of a-14-3-3I and II Ab failed to
show the interaction of 14-3-3 with PP2c (Figure 2D lower panel),
suggesting that the interaction detected by Far-WB is not stable
enough to detect by immunoprecipitation. Furthermore, knock-
down of PP2c gene did not affect the morphology and the growth of
the T. brucei PCF cells (data not shown), suggesting that PP2c may
not be a physiological target for T. brucei 14-3-3 proteins in vivo.
To identify 14-3-3 interacting proteins containing a mode 3
motif with higher affinity than PP2c, we constructed chimeric
molecules by replacing the C-terminal end of PP2c with various
sequences of mode 3 motif found in the database (Table 1, except
for ACS sequence). Those chimeric proteins were expressed in
HEK293T cells and purified by immunoprecipitation, and the
affinity to GST-II +I was compared with wild type PP2c by Far-
WB analyses. Chimeras containing -RRRNSV (Tb09.211.0210)
and -KRRRSV (Tb10.70.2780: predicted SAP domain protein
termed p31-SAP in this manuscript) associated with GST-II +I
more tightly than wild type PP2c (Figure 3A, upper panel). In
order to examine whether p31-SAP binds to T. brucei 14-3-3
proteins through the mode 3 motif in vivo, Tet-inducible V5-tagged
p31-SAP or p31-SAP S286A (mode 3 motif mutant)-expressing T.
brucei PCF clones were established. Tet-induced or uninduced cell
lysates were subjected to immunoprecipitation with a-V5
monoclonal Ab followed by Western blotting with a mixture of
a-I and a-II-specific Ab (Figure 3B, upper panel). Western blotting
with a-V5 monoclonal Ab (Figure 3B, lower panel) serves as the
immunoprecipitation control. Importantly, p31-SAP but not p31-
SAP S286A, a mode 3 mutant, binds to 14-3-3I and II in vivo (PCF
cells) suggesting that the interaction is mediated by the mode 3
motif (Figure 3B). We then examined whether the p31-SAP-
derived mode 3 phosphopeptide interact with T. brucei 14-3-3
proteins. The synthetic phosphopeptide MGGGHVSGLKRR-
RpSV derived from p31-SAP was clearly detected by heterodi-
meric T. brucei 14-3-3I+II proteins whereas MGGGLTRSRpSL
dereived from PP2c-W was not detected as demonstrated pre-
viously (Figure 2C, Figure 4). The human 14-3-3f interacts with
both phosphopeptides but with the preferential binding to the
mode 3 peptide derived from p31-SAP (Figure 4). The human 14-
3-3f shows slightly higher affinity to the p31-SAP derived
phosphopeptide than T. brucei 14-3-3 (Figure 4). Overall data
suggest that human 14-3-3 proteins have higher affinity to all the
binding motifs used in our experiments than T. brucei 14-3-3
proteins. In addition, mutations in the putative critical amino acid
residues in both 14-3-3I (K77E) and II (K56E) (Figure S1) prevent
the binding to the p31-SAP derived peptide (Figure 4, GST-I
K77E +II K56E), suggesting that the structure of an amphipathic
groove that mediate the association of 14-3-3 proteins with
phosphopeptides are evolutionally conserved between far distant
organisms. Subtle difference(s) in the structure of the amphipathic
groove or the distinctive difference(s) in the structure of the
N- and/or C-termini, may affect the binding to the motifs. Since
Table 1. Putative mode 3 motif sequences possibly
phosphorylated by AGC kinase.
Peptide
sequence Gene ID Protein Features
-WLTRSRSLW Tb927.7.4020 Protein phosphatase 2C, putative (PP2C)
-RRRNSV Tb09.211.0210 Atypical dual specificity phosphatase,
putative
-KSKGKSG Tb927.4.3840 Nucleolar protein, putative
-VRVKTI Tb927.3.1490 Leucine-rich repeat protein (LRRP), putative
-RRLRSN Tb927.6.4390 Kinesin, putative
*-RSRSRRV Tb09.160.5130 Hypothetical protein, conserved
-IRCRTF Tb927.8.7020 Metallo-peptidase, Clan ME, Family M16
–EHRKSSIG Tb11.52.0001 Acyl-CoA binding protein, putative
-KRRRSV Tb10.70.2780 Predicted SAP domain protein (p31-SAP)
-LIEGRKQTVG Tb927.8.2520 Acetyl-CoA synthetase, putative (ACS)
*This sequence is not –pS/pTx1-2-COOH, but when C-terminal V is removed in
vivo, it becomes –pS/pTx1-2-COOH.
doi:10.1371/journal.pone.0015566.t001
Binding Motifs of T. brucei 14-3-3 Proteins
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15566no phosphopeptide was known to interact with T. brucei 14-3-3
proteins until now, the affinity purification method eluting with a
specific phosphopeptide or a high-affinity peptide antagonist of 14-
3-3 proteins, which is successfully employed to isolate a great
number of 14-3-3-interacting proteins in other organisms [13,15],
has not been possible. The newly identified high-affinity phospho-
peptide (HVSGLKRRRpSV) is the first available phosphopeptide
that can be utilized for the affinity purification of 14-3-3-binding
proteins in T. brucei and for the subsequent identification of novel
binding motifs (unpublished data).
T. brucei 14-3-3 proteins exhibit far lower affinity to the
evolutionally conserved consensus binding motifs (modes1 and 2)
and slightly lower affinity to the newly identified mode 3 sequence
when compared to those in human 14-3-3 proteins, representing
the atypical nature of T. brucei 14-3-3 proteins. Considering the
affinity to the phosphopeptides, T. brucei 14-3-3 proteins might not
only act as phosphoserine-dependent binding proteins but also act
as binding proteins utilizing hitherto unknown consensus motifs.
Thus, the functions of 14-3-3 proteins in protozoan organisms
such as trypanosomatids, the most divergent eukaryote from
mammals, may need to be reconsidered. Further investigation of
the atypical nature of T. brucei 14-3-3 proteins and the unidentified
binding proteins may help identify novel drug targets since 14-3-3
proteins are essential to the survival of the parasite [14].
Materials and Methods
Construction of GST-I and II mutants
Mutations were made using the following primers:
I K77E: 59-gagaacgttatcggttcccgtcgcaa-39,5 9-gtacgccatcgagag-
caggttacg-39; and II K56E: 59-gaaaacgtcattggagcccgtcgt-39,5 9-
atacgcgacggagagaagattgc-39. The sequences were confirmed.
Construction of pLew82T7bsr N-V5 PP2c, pCR3 N-V5
PP2c
The PP2c-coding sequence (Tb927.7.4020: protein phosphatase
2C, putative) was amplified by PCR using primers 59-atgtatac-
cagtgttagaaagcct-39 and 59-gggccgcaacctgtctcctcataacat-39. The
Figure 2. Interaction of T. brucei PP2c with T. brucei and human 14-3-3 proteins. (A) and (B) Mammalian expression vectors pCR3 N-V5-PP2c,
–PP2c S744A or -C-terminal mutants of PP2c were transiently transfected to HEK293T cells. The cell lysates were subjected to immunoprecipitation
with a-V5 Ab followed by far-Western blot analyses (Far-WB) using indicated probes (upper panel). Immunoprecipitated proteins were reprobed with
a-V5 Ab (lower panel). (C) Modes 1-3 phosphopeptides summarized in Table 1 have far less affinity to T. brucei 14-3-3 than human 14-3-3f proteins.
Indicated biotinylated phosphopeptides were mixed with streptavidine and spotted to nitrocellulose filters and dried. The filters were then incubated
with indicated GST-14-3-3 proteins and detected with a-GST antibodies. (D) Tet-inducible T. brucei expression vector, pLew82 T7bsr-N-V5-PP2c was
transfected and clones were isolated with blasticidin selection. Tet-uninduced (Tet2) or –induced (Tet +) cell lysates of the clone were subjected to
immunoprecipitation followed by Western blotting using a mixture of a-I and II Ab (lower panel), and horseradish peroxidase (HRP)-labeled a-V5 Ab
(upper panel).
doi:10.1371/journal.pone.0015566.g002
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(pLew82 is a kind gift from Dr. George Cross) and PCR3 N-V5
(PCR3 is purchased from Invitrogen) at the HpaI site. (The
pLew82 vector was modified by the insertion of annealed
oligonucleotides of weak T7 promoter at the BamHI site. The
sequences of oligonucleotides are as follows: 59-GATCCTTA-
ATACGTCTCACTATAGGGA-39, and 59-GATCTCCCTA-
TAGTGAGACGTATTAAG-39. Permanent transfectants with
pLew82 T7 vector do not require 1 ng/ml Tet for maintenance of
the clones, while pLew82 transfectants do. The N-terminal V-5 tag
sequence and HpaI site were introduced in the pLew82T7 vector
to make pLew82T7 N-V5. Drug selection maker was replaced
with a blasticidin-resistance gene, which was designated as
pLew82T7bsrN-V5.)
Construction of pLew82T7bsrN-V5 p31-SAP
The P31-SAP-coding (Tb10.70.2780: predicted SAP domain
protein) sequence was amplified by PCR using primers 59-
atgaggaaacccgggcggaaaatt-39 and 59-acgggtgctgataatgtaaccaa-39.
The amplified sequence was inserted in the vector. The mutants
were created using PCR and the sequences were confirmed.
Construction of C-terminal PP2C mutants
The C-terminal HpaI site in the PP2c gene and the XbaI site in
the vector were used to insert the annealed oligonucleotides
encoding the indicated amino acid sequences.
Raf259 peptide pull-down assay
Ten ml of streptavidin agarose beads (Sigma Chemical Co., St.
Louis, MO) were incubated with 10 ml of 100 mM of pRaf 259
(biotin- MAGGGRQRSTSTPN) and/or pSRaf 259 at room
temperature for 30 min and the beads were washed three times
with lysis buffer (150 mM NaCl, 10 mM HEPES, pH 7.5, 0.2%
Figure 3. p31-SAP binds to T. brucei 14-3-3 proteins in vivo (PCF cells). (A) C-terminal chimeric PP2c proteins were produced by transfection
of HEK293T cells and purified by immunoprecipitation with a-V5 Ab. Immunoprecipitated proteins were analyzed by Far-WB with GST-II + I as a probe
(upper panel). Immunoprecipitated V5-tagged proteins were visualized with a-V5 Ab (lower panel). [*PP2c, **PP2c W (-)] (B) Full-length V5-tagged
p31-SAP or –SAP (S286A)-expressing cell lines under the control of tetracycline (Tet) were established. Cell lysates of clones with (+) or without (-) Tet-
induction were subjected to immunoprecipitation with a-V5 Ab followed by Western blotting (WB) with a mixture of a-14-3-3I and II Abs (upper
panel). Western blotting with HRP-labeled a-V5 monoclonal Ab (lower panel, WB: a-V5) serves as the immunoprecipitation control. Associated 14-3-3
proteins with V5-tagged p31-SAP, and IgG heavy chain (H) are indicated with arrows (upper panel) and precipitated total V5-p31-SAP or –SAP (S286A)
proteins are indicated (lower panel).
doi:10.1371/journal.pone.0015566.g003
Figure 4. Identification of the high-affinity mode 3 phospho-
peptide derived from p31-SAP. Indicated biotinylated mode 3
phosphopeptides (1 and 2) as indicated were mixed with streptavidine
and spotted to nitrocellulose filters and dried. The filters were then
incubated with the indicated GST-14-3-3 proteins and detected with a-
GST antibodies.
doi:10.1371/journal.pone.0015566.g004
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inhibitor tablets). Next, 1610
9 cells of T. brucei PCF were lysed
with 2 ml of the lysis buffer on ice. Insoluble proteins were pelleted
and 1 ml of the supernatant was used for each peptide pull-down
assay. The lysates were incubated with each bead, rotated at 4uC
for 2 hrs and washed with the lysis buffer three times. Twenty mlo f
2xSDS Gel loading buffer with 2-mercaptoethanol were added to
the washed beads, and 5 ml of eluates were run on 10–20% SDS-
PAGE. The blots were detected with a-I and/or a–II Abs as
described previously [14].
Production and purification of heterodimeric 14-3-3
proteins with glutathione S-transferease (GST), GST-II +I
The coding sequences of T. brucei 14-3-3I and II were subcloned
into pRSFDuet-1 (Novagen) and pGEX6P1 (GE-Healthcare. Both
constructs were simultaneously used to transform BL21 (T7
Express lysY/Iq competent E. coli, NEB). After IPTG-induction,
purification was carried out using glutathione beads (GE-
Healthcare). SDS-PAGE analysis of the purified proteins showed
two distinctive bands, GST-14-3-3II and 14-3-3I without a
peptide-tag, with equal molar ratio (data not shown).
Surface plasmon resonance measurements
The surface plasmon resonance measurement was carried out
using BIAcore 2000. A resonance unit value of 220 of biotinylated
phosphopeptide pSRaf 259 (biotin-MAGGGRQRSTpSTPN)
(mode 1 peptide) was coupled to a streptavidin-coated sensor chip
(SA5, BIAcore). In the next step, 200 nM each of purified GST-
14-3-3I, GST-14-3-3II, and GST–14-3-3t, or 500 nM each of
MBP-14-3-3I, MBP-14-3-3II, and MBP-14-3-3t in HBS-EP buffer
(BIAcore) was injected at a flow rate of 20 ml/min. A resonance
unit value of 296 of biotinylated mode 2 peptide (biotin-
MAGGGRLYHpSLP) was also coupled to SA5 and 200 nM each
of GST-14-3-3I, GST-14-3-3II and GST-14-3-3t in HBS-EP
buffer, and was injected in the same manner.
Transfection and establishment of clones
Transfection and cloning of T. brucei 29-13 procyclic cells (a kind
gift from George Cross) were performed as previously described
[23]. Finally, 1 mg/ml of Tet was added upon induction of the
genes. Transfection of SV40 large T-antigen-transformed human
embryonic kidney (HEK 293T) cells (Gene Hunter Corporation)
was performed using Fugene 6 transfection reagent (Roche).
Interaction of GST-14-3-3I, -II and t with human c-Raf
HeLa cell lysates were prepared using NP-40 lysis buffer
(150 mM NaCl, 10 mM HEPES, pH 7.5, 0.2% NP-40, 50 mM
NaF, 1 mM Na3VO4 and Roche protease inhibitor tablets) and
subjected to GST pull-down assay. Bound proteins were separated
with SDS-PAGE, transferred to a PVDF membrane and detected
with anti-human c-Raf-1 antibodies (Santa Cruz Biotechnology,
Santa Cruz, CA).
Far-Western blot analysis
Far-Western blot analysis of Ser/Thr phosphatase inhibitor
Calyculin A (CalA) treated + and/or untreated – of HeLa and/or
29-13 PCF cell lysates was performed. HeLa cells and/or 29-13
PCF cells were lysed with SDS-gel loading buffer supplemented
with 2-mercaptoethanol (Bio-Rad, Hercules, CA) and sonicated.
The cell lysates equivalent to 5610
5 HeLa cells and 1610
7 29-13
PCF cells were applied on 4–20% SDS-PAGE (Daiichi, Japan)
and transferred to nitrocellulose filters (Millipore, Bedford, MA).
The filters were denatured with denaturation buffer (6M
guanidine-HCl, 50 mM Tris-HCl, pH 8.0, and 1 mM dithiothre-
itol [DTT]). The denaturation buffer was then diluted with an
equal volume of 50 mM Tris-HCl, pH 8.0 with 1 mM DTT.
After 15 min of denaturation, the filters were then treated with 2x
diluted denaturation buffer. The same step was repeatedly carried
out eight times and then renatured filters were washed twice with
TTBS (50 mM Tris-HCl, pH 7.4, 0.1% Tween 20, and 150 mM
NaCl). The resultant filters were blocked with TTBS containing
4% skim milk plus 1 mM DTT. Then the filters were incubated
overnight with 1 or 2 mg/ml of GST-14-3-3 probes in 4% skim
milk containing the blocking solution at 4uC. The filters were
washed three times with TTBS and incubated with anti-GST
polyclonal antibodies (Sigma) followed by horseradish peroxidase
(HRP)-labeled anti-rabbit goat IgG (Jackson Immunoresearch
Laboratories, West Grove, PA).
Immunoprecipitation
Immunoprecipitation was carried out using NP-40 lysis buffer.
Anti-V5 monoclonal Ab and sepharose suspension protein G
(protein G beads) were purchased from Nacalai and Invitrogen,
respectively. In brief, cells were lysed on ice for 30 min and spun at
15,000 rpm for 10 min. The resultant supernatants were used for
immunoprecipitation using 5 ml of protein G beads and 1 mgo fa-
V5 monoclonal Ab.
NC-filter binding assay
Five ml of 1 mM biotinylated peptides, purchased from Scrum
(Japan) were mixed with 15 ml of streptavidine (1 mg/ml) in the
presence of 0.1% Tween20, spotted on NC-filters and dried.
Filters were washed with TTBS, blocked with Protein-Free
Blocking Buffer (Pierce), and then incubated with GST-14-3-3
proteins in TTBS containing 20% Protein-Free Blocking Buffer
and 1 mM DTT. The filters were extensively washed four times
with TTBS, and detected with anti-GST antibodies.
Supporting Information
Figure S1 Amino acid sequence alignment of T. brucei 14-3-3I,
II, human 14-3-3t, and f. The amphipathic groove structures are
comprised of a-helices 3, 5, 7 and 9 as shown in green lines.
Amino acid residues directly engaged in the conserved phospho-
peptide bindings are boxed in red. Identical amino acid residues
are colored in magenta.
(TIF)
Figure S2 Far-western blot (Far-WB) analyses of the binding
proteins for human and T. brucei 14-3-3 proteins. (A) The nature of
GST-14-3-3 probes, samples, and the calyculin A (CalA) treatment
are indicated. (B) The effect of 1 mM CaCl2 on T. brucei 14-3-3
binding was determined by Far-WB analysis. Data are represen-
tatives of three independent experiments.
(TIF)
Acknowledgments
We thank Drs. Noriya Ota and Makoto Hiromura for their helpful
comments. We also thank Dr. Gorge M. Cross for the pLew82 vector and
29–13 cells, In addition, we thank Ms. Manami Ohba for manuscript
preparation, and Ms. Kaori Sugimoto (Scrum) for peptide synthesis.
Author Contributions
Conceived and designed the experiments: MI. Performed the experiments:
MI KY NY HI. Analyzed the data: MI KY HU YS NH TF. Contributed
reagents/materials/analysis tools: MI TF. Wrote the paper: MI HU NH.
Binding Motifs of T. brucei 14-3-3 Proteins
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15566References
1. Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with
signaling proteins is mediated by the recognition of phosphoserine. Cell 84:
889–897.
2. Yaffe MB (2004) Master of all things phosphorylated. Biochem J 379: e1–2.
3. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, et al. (2005)
The genome of the African trypanosome Trypanosoma brucei. Science 309:
416–422.
4. Rosenquist M, Sehnke P, Ferl RJ, Sommarin M, Larsson C (2000) Evolution of
the 14-3-3 protein family: does the large number of isoforms in multicellular
organisms reflect functional specificity? J Mol Evol 51: 446–458.
5. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, et al. (1997) The
structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91: 961–971.
6. Wu M, Coblitz B, Shikano S, Long S, Cockrell LM, et al. (2006) SWTY–a
general peptide probe for homogeneous solution binding assay of 14-3-3
proteins. Anal Biochem 349: 186–196.
7. Coblitz B, Wu M, Shikano S, Li M (2006) C-terminal binding: an expanded
repertoire and function of 14-3-3 proteins. FEBS Lett 580: 1531–1535.
8. Aitken A (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol 16:
162–172.
9. Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function,
and regulation. Annu Rev Pharmacol Toxicol 40: 617–647.
10. Wilker E, Yaffe MB (2004) 14-3-3 Proteins–a focus on cancer and human
disease. J Mol Cell Cardiol 37: 633–642.
11. Gardino AK, Smerdon SJ, Yaffe MB (2006) Structural determinants of 14-3-3
binding specificities and regulation of subcellular localization of 14-3-3-ligand
complexes: a comparison of the X-ray crystal structures of all human 14-3-3
isoforms. Semin Cancer Biol 16: 173–182.
12. Johnson C, Crowther S, Stafford MJ, Campbell DG, Toth R, et al. (2010)
Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J 427:
69–78.
13. Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, et al.
(2004) 14-3-3-affinity purification of over 200 human phosphoproteins reveals
new links to regulation of cellular metabolism, proliferation and trafficking.
Biochem J 379: 395–408.
14. Inoue M, Nakamura Y, Yasuda K, Yasaka N, Hara T, et al. (2005) The 14-3-3
proteins of Trypanosoma brucei function in motility, cytokinesis, and cell cycle.
J Biol Chem 280: 14085–14096.
15. Meek SE, Lane WS, Piwnica-Worms H (2004) Comprehensive proteomic
analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem 279:
32046–32054.
16. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, et al. (1995) Structure of
a 14-3-3 protein and implications for coordination of multiple signalling
pathways. Nature 376: 188–191.
17. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, et al. (1995) Crystal structure
of the zeta isoform of the 14-3-3 protein. Nature 376: 191–194.
18. Irie K, Gotoh Y, Yashar BM, Errede B, Nishida E, et al. (1994) Stimulatory
effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase.
Science 265: 1716–1719.
19. Van Der Hoeven PC, Van Der Wal JC, Ruurs P, Van Dijk MC, Van
Blitterswijk J (2000) 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to
Raf-1: negative regulation by 14-3-3 phosphorylation. Biochem J 345 Pt 2:
297–306.
20. Tzivion G, Luo ZJ, Avruch J (2000) Calyculin A-induced vimentin phosphor-
ylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo. J Biol
Chem 275: 29772–29778.
21. Manak MS, Ferl RJ (2007) Divalent cation effects on interactions between
multiple Arabidopsis 14-3-3 isoforms and phosphopeptide targets. Biochemistry
46: 1055–1063.
22. Das A, Gale M, Jr., Carter V, Parsons M (1994) The protein phosphatase
inhibitor okadaic acid induces defects in cytokinesis and organellar genome
segregation in Trypanosoma brucei. J Cell Sci 107(Pt 12): 3477–3483.
23. Wirtz E, Leal S, Ochatt C, Cross GA (1999) A tightly regulated inducible
expression system for conditional gene knock-outs and dominant-negative
genetics in Trypanosoma brucei. Mol Biochem Parasitol 99: 89–101.
Binding Motifs of T. brucei 14-3-3 Proteins
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15566